These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 9473456)

  • 21. Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients.
    Tan Y; Zavala J; Xu M; Zavala J; Hoffman RM
    Anticancer Res; 1996; 16(6C):3937-42. PubMed ID: 9042316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey.
    Hoffman RM
    Expert Opin Biol Ther; 2015 Jan; 15(1):21-31. PubMed ID: 25439528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of cancer cells with methioninase produces DNA hypomethylation and increases DNA synthesis.
    Machover D; Zittoun J; Saffroy R; Broët P; Giraudier S; Magnaldo T; Goldschmidt E; Debuire B; Orrico M; Tan Y; Mishal Z; Chevallier O; Tonetti C; Jouault H; Ulusakarya A; Tanguy ML; Metzger G; Hoffman RM
    Cancer Res; 2002 Aug; 62(16):4685-9. PubMed ID: 12183426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective Metabolic Targeting of Human Osteosarcoma Cells
    Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
    Anticancer Res; 2017 Sep; 37(9):4807-4812. PubMed ID: 28870899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidis.
    Wang M; Basu A; Palm T; Hua J; Youngster S; Hwang L; Liu HC; Li X; Peng P; Zhang Y; Zhao H; Zhang Z; Longley C; Mehlig M; Borowski V; Sai P; Viswanathan M; Jang E; Petti G; Liu S; Yang K; Filpula D
    Bioconjug Chem; 2006; 17(6):1447-59. PubMed ID: 17105223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thermostability of native and pegylated Myceliophthora thermophila laccase in aqueous and mixed solvents.
    López-Cruz JI; Viniegra-Gonzalez G; Hernández-Arana A
    Bioconjug Chem; 2006; 17(4):1093-8. PubMed ID: 16848420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducible preparation and effective separation of PEGylated recombinant human granulocyte colony-stimulating factor with novel "PEG-pellet" PEGylation mode and ion-exchange chromatography.
    Yun Q; Yang RE; Chen T; Bi J; Ma G; Su Z
    J Biotechnol; 2005 Jul; 118(1):67-74. PubMed ID: 15904987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide.
    Fang J; Sawa T; Akaike T; Maeda H
    Cancer Res; 2002 Jun; 62(11):3138-43. PubMed ID: 12036926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
    Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
    Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEGylated recombinant human tumor necrosis factor alpha: preparation and anti-tumor potency.
    Li YP; Pei YY; Ding J; Shen ZM; Zhang XY; Gu ZH; Zhou JJ
    Acta Pharmacol Sin; 2001 Jun; 22(6):549-55. PubMed ID: 11747763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of poly(ethylene glycol) conjugated lactoferrin for oral administration.
    Nojima Y; Suzuki Y; Iguchi K; Shiga T; Iwata A; Fujimoto T; Yoshida K; Shimizu H; Takeuchi T; Sato A
    Bioconjug Chem; 2008 Nov; 19(11):2253-9. PubMed ID: 18834167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Afterword: Oral Methioninase-Answer to Cancer and Fountain of Youth?
    Hoffman RM; Han Q; Kawaguchi K; Li S; Tan Y
    Methods Mol Biol; 2019; 1866():311-322. PubMed ID: 30725426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PEGylated murine Granulocyte-macrophage colony-stimulating factor: production, purification, and characterization.
    Sainathan SK; Tu L; Bishnupuri KS; Han M; Li A; Newberry RD; McDonald KG; Crimmins DL; Houchen C; Anant S; Dieckgraefe BK
    Protein Expr Purif; 2005 Dec; 44(2):94-103. PubMed ID: 16213750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
    Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
    Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The preparation of endotoxin-free L-methionine-alpha-deamino-gamma-mercaptomethane-lyase (L-methioninase) from Pseudomonas putida.
    Lishko VK; Lishko OV; Hoffman RM
    Protein Expr Purif; 1993 Dec; 4(6):529-33. PubMed ID: 8286949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
    Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
    Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.
    Kawaguchi K; Han Q; Li S; Tan Y; Igarashi K; Kiyuna T; Miyake K; Miyake M; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Singh AS; Eckardt MA; Unno M; Eilber FC; Hoffman RM
    Cell Cycle; 2018; 17(3):356-361. PubMed ID: 29187018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model.
    Baker DP; Lin EY; Lin K; Pellegrini M; Petter RC; Chen LL; Arduini RM; Brickelmaier M; Wen D; Hess DM; Chen L; Grant D; Whitty A; Gill A; Lindner DJ; Pepinsky RB
    Bioconjug Chem; 2006; 17(1):179-88. PubMed ID: 16417267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
    Murakami T; Li S; Han Q; Tan Y; Kiyuna T; Igarashi K; Kawaguchi K; Hwang HK; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Hiroshima Y; Lwin TM; DeLong JC; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
    Oncotarget; 2017 May; 8(22):35630-35638. PubMed ID: 28404944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.